Ignite Creation Date:
2025-12-24 @ 2:43 PM
Ignite Modification Date:
2026-04-30 @ 4:59 AM
Study NCT ID:
NCT00742859
Status:
COMPLETED
Last Update Posted:
2023-08-07
First Post:
2008-08-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin
Sponsor:
Portola Pharmaceuticals
Organization: